Click here to load reader
Upload
tedlucay
View
15
Download
7
Embed Size (px)
DESCRIPTION
Research paper on fibrin glue (autologous))
Citation preview
ORIGINAL ARTICLE AESTHETIC
Use of Autologous Fibrin Glue (Platelet-Poor Plasma)in Abdominal Dermolipectomies
Angelica Maria Schettino • Diogo Franco •
Talita Franco • Joao Medeiros Tavares Filho •
Fabiel Spani Vendramin
Received: 26 January 2012 / Accepted: 17 July 2012
� Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2012
Abstract
Background Autologous plasma is endowed with prop-
erties that speed up healing, hemostasis, and adhesiveness,
in addition to growth factors. Through an established pro-
tocol, it was possible to isolate thrombin, as well as the
platelet-rich plasma (PRP) and platelet-poor plasma (PPP)
fractions. The purpose of this study was to analyze autol-
ogous use of thrombin and PPP to foster adhesion between
an abdominal dermoadipose flap and the aponeurotic sur-
face in abdominal dermolipectomies.
Methods The data from 40 patients who underwent
abdominal dermolipectomies were analyzed, with 20
patients using thrombin and autologous PPP (Plasma
group) and 20 patients with no intervention (Control
group). An attempt was made to assess adhesive power by
quantifying the serohematic liquid volume gauged during
the postoperative days (POD), and also noting the inci-
dence of seroma. Other variables such as age and body
mass index (BMI) were also analyzed.
Results The reduction in the aspiration drain debit was
statistically relevant only on the first POD in the Plasma
group. There was no reduction in the incidence of seroma
in these patients. Similarly, age and BMI did not influence
these outcomes.
Conclusion The PPP fostered adhesion between the
abdominal dermoadipose flap and the aponeurotic surface
only on the first POD and had no influence whatsoever on
the incidence of seroma. There are few reports on the use
of PPP for plastic surgery, particularly the autologous type,
opening up possibilities for further research projects to
expand its use.
Level of Evidence III This journal requires that authors
assign a level of evidence to each article. For a full
description of these Evidence-Based Medicine ratings,
please refer to the table of contents or the online instruc-
tions to authors www.springer.com/00266
Keywords Platelet-rich plasma � Plasma � Plastic surgery
Introduction
Abdominal dermolipectomy is a surgical procedure that is
undertaken frequently, with seroma a common complica-
tion [1–3], with an incidence of up to 90 % reported for
this type of surgery [4]. In the latest publications, a seroma
incidence of up to 10 % is accepted for dermolipectomies,
although this figure varies depending on the experience of
the surgeon and the body mass index (BMI) of the patient,
in parallel to increasing frequency of seroma in operations
associated with lipoaspiration [4].
Among the latest scientific novelties, fibrin glue is a
promising option for tissue adhesion, with reduced post-
operative edema and the need for drains. It also helps
reduce the occurrence of liquid buildup, seroma, and
hematoma [5]. It is usually produced through plasmaphe-
resis, using a pool of known donors, while thrombin is
animal (bovine) in origin. Inconvenient aspects of fibrin
glue include high cost, the possibility of allergic reaction
A. M. Schettino (&) � D. Franco � T. Franco � J. M. T. Filho
Federal University of Rio de Janeiro, Rua Professor Gabizo,
101 apto. 202-Tijuca, Rio de Janeiro CEP: 20271-063, Brazil
e-mail: [email protected]
A. M. Schettino
Marcilio Dias Navy Hospital, Rio de Janeiro,
Brazil
F. S. Vendramin
Federal University of Para, Belem, Para, Brazil
123
Aesth Plast Surg
DOI 10.1007/s00266-012-9978-y
(as the origin of this substance is bovine), and viral trans-
missions (B19 parvovirus, hepatitis, and HIV), despite
modern viral neutralization techniques [6]. However,
research projects investigating plasma (as well as its
platelet-rich and platelet-poor fractions) offer opportunities
of using an autologous substance with adhesive, healing,
and hemostatic properties at low cost [7–9].
The purpose of this study was to demonstrate the use of
platelet-poor plasma (PPP), also known as fibrin glue, as an
adhesive element in abdominal dermolipectomies and
analyze its action and its effect on the incidence of seroma
among these patients.
Materials and Methods
This study followed 40 patients who underwent abdominal
dermolipectomy (Bozola level V) [10] and collecting data
on daily drainage volumes, length of time the aspiration
drain remained in place, and the incidence of seroma. The
first 20 patients underwent surgery using PPP in the supra-
aponeurotic surface, after resectioning excess skin and
immediately before positioning the dermoadipose flap
(Plasma group). The other 20 patients underwent abdomi-
nal dermolipectomy with no products applied (Control
group). A continuous aspiration drain was used for all
patients using the same surgical technique.
The PPP was isolated in an autologous manner through
successive centrifugation steps, following the protocol
developed by Vendramin et al. [11]. The thrombin used to
activate the plasma was also isolated through the same
protocol, also in an autologous manner (Fig. 1). The drains
were kept in place until the daily volume reached a max-
imum value of 50 ml/24 h.
The patients were between 20- and 60-year-old, with a
minimum hematocrit index of 37 %, normal laboratory
tests, a surgical risk rated at American Society of
Anesthesiologists (ASA) I or II according to the ASA , and
a BMI of no more than 27 kg/m2. All were women who
gave written informed consent. There was no association of
surgical procedures, and all patients wore surgical support
belts for at least three months after the operation (Fig. 2).
Results
Both groups were similar in terms of age, BMI, and labo-
ratory test results. The average volume on the first postop-
erative day (POD1) in the Plasma group (P group) was 53.2
and 105.1 ml on the POD2, with this difference being sig-
nificant (p = 0.006). There were no statistical differences
for the other POD in the P group. For the Control group (C
group), the mean aspiration drain volume for POD1 was
103.7 ml and for POD2 it was 105.2 ml. There was no
difference in volume on any other POD (Table 1). When
comparing the two groups, a statistically significant reduc-
tion in the aspiration drain debit was noted (p = 0.004) only
on the POD1 and was not repeated on the other POD
(Table 2). A curve of the mean daily volumes of both groups
versus POD (Fig. 3) was constructed, demonstrating a
reduction in the aspiration drain debit for patients in the P
group. Although it was statistically relevant only on the
POD1, it may be said that the plasma generally reduced the
volume from drains used in the operations.
Another evaluation measured the incidence of seroma,
noted at 20 % in the C group and reaching 35 % in the P
group. For all the patients who underwent surgery, the
incidence of seroma reached 27.5 %, mainly in the P group
(Table 3). Thus, comparing the two groups, there was no
statistical relevance in the incidence of seroma, with
p = 0.288, according to the v2 test analysis.
Finally, the BMI and seroma were analyzed for any
correlation between these variables. There were no statis-
tically significant findings between these data for either of
the two groups (Tables 4, 5).Fig. 1 Activation of plasma by thrombin
Fig. 2 Application of activated plasma to the aponeurotic surface
Aesth Plast Surg
123
Discussion
Platelets play an important role in coagulation and tissue
healing. Once platelets are activated, a lot of cytokines and
growth factors are released, which trigger important actions
such as hemostasis, coagulation, and healing. Their roles
are well known in healing chronic wounds and in knitting
partial skin grafts together [7–9, 11–14].
Two plasma fractions may be isolated from full blood,
thus constituting a concentrate with a higher or lower level
of platelets: platelet-rich plasma (PRP) and PPP. There are
various types of protocols available in the literature [11,
14–18]. The protocol used in this study produces outcomes
similar to those found by the main authors in this field and
can isolate both plasma fractions at the same time. Fur-
thermore, it is also possible to isolate and produce the
thrombin that is used to activate the plasma. This produc-
tion method makes the use of activated plasma safer
because it works with autologous rather than bovine
thrombin. Thus, platelet-rich and platelet-poor autologous
plasma are endowed with properties that are important for
healing, adhesion, and hemostasis. The PPP is compared to
fibrin glue and is, in fact, known by this name by several
authors [9, 19–22] as it is endowed with a sealing action
similar to industrially produced glue. The use of autologous
Table 1 Descriptive statistics of serohematic liquid volumes (ml) by
POD
Descriptive statistics 1
POD
2
POD
3
POD
4
POD
5
POD
6
POD
Plasma group
N 20 20 17 11 5 2
Mean 53.2 105.1 70.5 50.5 36.0 60.5
Standard deviation 26.7 101.8 38.1 23.8 24.1 29.0
Minimum 10.0 20.0 14.0 20.0 0.0 40.0
Median 62.0 75.0 67.0 50.0 45.0 60.5
Maximum 102.0 450.0 185.0 107.0 62.0 81.0
Control group
N 20 20 19 13 9 4
Mean 103.7 105.2 78.4 68.2 57.0 52.3
Standard deviation 65.8 63.9 42.9 39.5 17.8 9.9
Minimum 13.0 35.0 30.0 18.0 35.0 45.0
Median 91.5 85.0 64.0 64.0 55.0 49.0
Maximum 248.0 273.0 178.0 150.0 90.0 66.0
p-value by the
Mann-Whitney test
(comparison
between the
groups)
0.004 0.441 0.763 0.339 0.159 1.000
Table 2 Comparison between the POD1 and other days, among days and between groups
Descriptive statistics 2 POD 3 POD 4 POD 5 POD 6 POD
Plasma group
N 20 17 11 5 2
Mean 51.9 17.7 -9.2 -30.6 -23.0
Standard deviation 94.4 37.9 25.4 52.4 2.8
Minimum -45.0 -51.0 -50.0 -102.0 -25.0
Median 29.5 14.0 -10.0 -35.0 -23.0
Maximum 348.0 96.0 40.0 38.0 -21.0
p-value (Wilcoxon test) 0.006 0.072 0.182 0.225 0.180
Control group
N 20 19 13 9 4
Mean 1.5 -26.8 -29.0 -42.0 -33.5
Standard deviation 80.2 91.7 84.7 75.5 61.8
Minimum -155.0 -218.0 -156.0 -175.0 -97.0
Median 1.5 -15.0 -25.0 -32.0 -44.0
Maximum 190.0 165.0 135.0 55.0 51.0
p-value by the Wilcoxon test (comparison of days with a POD1) 0.955 0.191 0.249 0.161 0.465
p-value by the Mann-Whitney test (comparison between the groups) 0.064 0.035 0.325 0.947 0.355
Table 3 Incidence of seroma in the Plasma and Control groups
Group Total Without
seroma
Seroma p-value
by the test
n % n % n % v2
Plasma 20 100.0 13 65.0 7 35.0 0.288
Control 20 100.0 16 80.0 4 20.0
Total 40 100.0 29 72.5 11 27.5
Bold values indicate the percentual of patients that did not have
seroma
Aesth Plast Surg
123
thrombin and PPP eliminates the possibility of viral
transmission and allergic reactions.
With the use of PPP in abdominal dermolipectomy, we
analyzed its sealing and hemostatic powers, noting that its
behavior is similar to that of industrial glue. There are few
reports on the use of PPP in surgery, particularly the
autologous type. This plasma fraction was selected because
it has been compared to biologic glues and because of its
adhesive action. We chose to use it for abdominal
dermolipectomy because this operation involves ample
tissue separation and there was the possibility of monitor-
ing the daily aspiration drain debit. The incidence of ser-
oma also prompted this survey.
Satisfactory results on only the POD1 in the P group
shows that the PPP was effective in reducing liquid buildup
and exudation during the postoperative period, and when
comparing the outcomes for the two groups, there was a
significant reduction in the debit in the P group. The high
drain volumes on the subsequent POD, reaching levels
equivalent to those of the C group, may be explained by the
useful life span of the plasma and the conditions under
which the PPP was used. The application of PPP took place
at room temperature, and the plasma was activated and
Fig. 3 Postoperative volumes by group
Table 4 Descriptive statistics on age and BMI by seroma incidence in the Control group
Statistics Seroma p-value*
No (n = 16) Yes (n = 4)
Age (years) Mean 41.9 41.8 0.750
Standard deviation 8.9 15.4
Minimum 33.0 28.0
Median 38.0 39.5
Maximum 59.0 60.0
BMI (kg/m2) Mean 23.4 23.4 0.963
Standard deviation 2.1 2.1
Minimum 19.5 21.6
Median 23.9 23.3
Maximum 26.1 25.6
*Mann-Whitney test
Table 5 Descriptive statistics on age and BMI by seroma incidence in the Plasma group
Statistics Seroma p-value*
No (n = 13) Yes (n = 7)
Age (years) Mean 39.4 45.4 0.211
Standard deviation 11.6 9.6
Minimum 23.0 31.0
Median 35.0 47.0
Maximum 60.0 60.0
BMI (kg/m2) Mean 23.2 23.4 0.877
Standard deviation 2.3 2.0
Minimum 18.1 20.7
Median 23.9 23.6
Maximum 26.4 25.5
*Mann-Whitney test
Aesth Plast Surg
123
applied with thrombin up to 4 h after it was made. The
importance of the plasma temperature is related to its sta-
bility and viability; at temperatures between 22 �C and
24 �C, plasma must be used within 5 h [23].
Several attempts have been made in plastic surgery to
develop techniques and tactics for reducing the volume and
incidence of seroma. A seroma rate of up to 10 % is
acceptable, but in the literature it ranges from 0.3 to 90 %
[6]. There have also been discussions on what might
influence the incidence of seroma. There are some firmly
established techniques for reducing seroma in abdomino-
plasty, such as the Saldanha [24] technique and Baroudi
[25] stitches. However, although the Saldanha surgical
technique has had good outcomes in terms of reducing the
incidence of seroma, its use is limited, particularly for
operations in which large abdominal volumes are resec-
tioned. In addition, the association of lipoaspiration with
surgery was excluded here.
Thus, the incidence of seroma in this study, 35 % in the
P group and 20 % in the C group, was higher than the mean
rate accepted in some studies, with no statistical relevance
when the groups are compared (p = 0.288). The P group
had more seroma but it can not be said that this (the use of
PPP) was the determining factor in this occurrence.
The absence of correlation between seroma and BMI
was also noted in both groups, contradicting the daily
practice of all plastic surgeons, particularly because a
higher seroma index is noted in overweight patients. The
absence of correlation may be related to the inclusion
factors for this study, which limited patient BMI to 27 kg/
m2, thus excluding overweight or obese patients. Thus,
sufficient data were not available to analyze whether this
variable might be effective. In future studies, the BMI
should not be limited, obviously provided that this is not a
clear counterindication for the operation.
The cost of obtaining autologous plasma, considering
both plasma fractions, was lower than that of industrial
glue. The average amount spent on this autologous pro-
duction varied between US$12.00 and US$30.00, which is
very different from the cost of industrial glues or machines
that produce PRP with kits, which are around US$175.00/
ml. In fact, the need for PRP production kits, whether
autologous or not, also hampers its use. All this merely
underscores the need to extend research in this field of
medicine, making better use of substances that speed up
healing and make flap adhesiveness a reality.
Conclusion
Platelet-poor plasma reduced the continuous aspiration drain
debit in the patients studied only during the POD1. There was
no link between the incidence of seroma and PPP. In the P
group, the BMI did not influence the incidence of seroma.
This consequently indicates the need for additional studies to
examine the properties and possibilities of plasma use, for
both fractions, including comparative studies on the out-
comes of autologous and industrial production. Furthermore,
the use of autologous plasma must be extended in operations
in various specialties to open up greater possibilities and
achieve more discoveries with this substance.
Conflict of interest The authors have no conflict of interest to
disclose
References
1. Brazilian Society of Plastic Surgeons (2009) Surgery statistics.
www.cirurgiaplastica.org.br. Accessed 14 September 2010
2. American Society of Plastic Surgeons. National Clearinghouse of
Plastic Surgery Statistics. www.plasticsurgery.org. Accessed 23
March 2011
3. Kim J, Stevenson TR (2006) Abdominoplasty, liposuction of the
flanks and obesity: analyzing risk factors for seroma formation.
Plast Reconstr Surg 117:773–779
4. Di Martino M, Nahas FX, Barbosa MV, Montecinos Ayaviri NA,
Kimura AK, Barella SM, Novo NF, Ferreira LM (2010) Seroma
in lipoabdominoplasty and abdominoplasty. a comparative study
using ultrasound. Plast Reconstr Surg 126(5):1742–1751
5. Marchac D, Sandor G (1994) Face lifts and sprayed fibrin glue:
an outcome analysis of 200 patients. Br J Plast Surg 47:306–309
6. Rasedovich M, Goubran HA, Burnouf T (1997) Fibrin sealant:
scientific rationale, production methods, properties and current
clinical use. Vox Sang 72:133–143
7. Marx RE (2004) Platelet rich plasma: evidence to support its use.
J Oral Maxillofac Surg 62:489–496
8. Marx RE, Carlson ER (1998) Platelet-rich plasma: growth factors
enhancement for bone grafts. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod 85:638–646
9. Man D, Plosker H, Winland-Brown JE (2001) The use of autol-
ogous platelet rich plasma (platelet gel) and autologous platelet
poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg
107:229–237
10. Bozola AC, Bozola AR (2003) Abdominoplastias. In: Melega JM
(ed) Cirurgia plastica: fundamentos e arte. Sao Paulo, Medsi,
pp 609–623
11. Vendramin FS, Franco D, Nogueira CM, Pereira MS, Franco T
(2006) Plasma rico em plaquetas e fatores de crescimento: tecnica
de preparo e utilizacao em cirurgia plastica. Rev Col Bras Cir
33:24–28
12. Eppley BL, Woodell JE, Higgins J (2004) Platelet quantification
and growth factor analysis from platelet-rich plasma: implica-
tions for wound healing. Plast Reconstr Surg 114:1502–1508
13. Vendramin FS, Franco D, Franco T (2010) Utilizacao de plasma
rico em plaquetas autologo nas cirurgias de enxertos cutaneos em
feridas cronicas. Rev Bras Cir Plast 25:589–594
14. Grageda E (2004) Platelet-rich plasma and bone graft materials: a
review and a standardized research protocol. Implant Dentistry
13:301–309
15. Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M
(2009) The use of autologous PRP gel as an aid in the manage-
ment of acute trauma wounds. Injury 40:801–805
16. Zucchelli P, Silvestri AR (2004) Production and use of fibrin glue
at blood transfusion service of Bellaria-Maggiore Hospital
Bologna. Transfus Apher Sci 30:157–161
Aesth Plast Surg
123
17. Findikcioglu K, Findikcioglu F, Yavuzer R, Elmas C, Atabay K
(2009) Effect of platelet rich plasma and fibrin glue on heal-
ing critical-size calvarian bone defects. J Craniofac Surg 20:
34–40
18. Albanyan AM, Sukhu K, Harrison P (2009) Evoluation of the
PDQ centrifuge for preparing platelet rich, platelet poor and
platelet free plasma samples for light transmition aggregometry
and microparticle measurement. Platelets 20:610–612
19. Bhanot S, Alex JC (2002) Current application of platelet gels in
facial plastic surgery. Facial Plast Surg 18:27–33
20. Petrungaro PS (2001) Using platelet rich plasma to accelerate soft
tissue maturation in aesthetic periodontal surgery. Compend
Contin Educ Dent 22:729–736
21. Tischler M (2002) Platelet rich plasma. The use of autologous
growth factors to enhance bone and soft tissue grafts. NY State
Dent J 68:22–24
22. Mann KG (2003) Thrombin formation. Chest 124:4S–10S
23. Taube J, McWilliam N, Luddington R, Byrne CD, Baglin T
(1999) Actived protein C resistance: effect of platelet activation,
platelet-derived microparticles and atherogenic lipoproteins.
Blood 11:3792–3797
24. Saldanha OR, Pinto EBDS, Mattos Junior WN, Pazetti CE,
Bello EML (2003) Lipoabdominoplasty with selective and safe
undermining. Aesthet Plast Surg 27:322–327
25. Baroudi R, Ferreira CAA (1998) Seroma: how to avoid it. Aesthet
Surg J 18:439–441
Aesth Plast Surg
123